Ovid Therapeutics (STU:1OT) 3-Year Revenue Growth Rate : -69.70% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ovid Therapeutics 3-Year Revenue Growth Rate?

Ovid Therapeutics's Revenue per Share for the three months ended in Sep. 2024 was €0.00.

During the past 12 months, Ovid Therapeutics's average Revenue per Share Growth Rate was 60.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -69.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of Ovid Therapeutics was -69.70% per year. The lowest was -69.70% per year. And the median was -69.70% per year.

Competitive Comparison of Ovid Therapeutics's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Ovid Therapeutics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovid Therapeutics's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ovid Therapeutics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ovid Therapeutics's 3-Year Revenue Growth Rate falls into.

Ovid Therapeutics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ovid Therapeutics (STU:1OT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ovid Therapeutics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ovid Therapeutics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovid Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovid Therapeutics Inc (STU:1OT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

OVID:USA

Address

441 Ninth Avenue, 14th Floor, New York, NY, USA, 10001

Website

https://www.ovidrx.com

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Ovid Therapeutics Headlines

No Headlines